If the "confirmation" of a negative screen is positive, all you have done is performed a more sensitive screen. The original result of negative was not confirmed, it was refutiated. For those immunoassays whose specific drug sensitivity is poor, screening and billing, and then screening and billing again using a more sensitive method "just in case" the first screen "missed" something is not good science nor good patient care. It is designed to maximize revenue for the lab.